Literature DB >> 8261149

Surgical treatment of intractable right-sided infective endocarditis in drug addicts: 25 years experience.

A Arbulu1, R J Holmes, I Asfaw.   

Abstract

During the past 25 years the authors have performed the following operations in the surgical treatment of intractable right-sided endocarditis in drug addicted patients: 1) Excision of the infected tricuspid valve and replacement with a mechanical or bioprosthetic valve during the same operation. In these patients the overall mortality was 100% due to: (a) inability to control the endocarditis in 80%; (b) re-infection due to a return to drug abuse and (c) fatal complications due to non-compliance with anticoagulant therapy. 2) Tricuspid valvulectomy in 53 patients, tricuspid and pulmonary valvulectomy without replacement in two patients. Six patients (11%) died within six weeks. Five due to the endocarditis and one due to low cardiac output. Ten patients (18%) died six months to 13 years later. In nine of these patients, death was related to continued drug abuse. At 22 years the actuarial survival is 64%. This experience supports the authors conclusion that among drug addicts with intractable right-sided endocarditis, tricuspid valvulectomy or tricuspid and pulmonary valvulectomy without replacement is/are the operation(s) of choice.

Entities:  

Mesh:

Year:  1993        PMID: 8261149

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  18 in total

Review 1.  Injection drug use and right sided endocarditis.

Authors:  Rob Moss; Brad Munt
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

2.  Tricuspid valve surgery.

Authors:  C A Mestres; G Fita; V M Parra; J L Pomar; J M Bernal
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012

3.  Tricuspid valve endocarditis.

Authors:  Syed T Hussain; James Witten; Nabin K Shrestha; Eugene H Blackstone; Gösta B Pettersson
Journal:  Ann Cardiothorac Surg       Date:  2017-05

Review 4.  Evidence-based surgical management of acquired tricuspid valve disease.

Authors:  Sung Ho Shinn; Hartzell V Schaff
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

5.  Surgery for tricuspid valve endocarditis: a selective approach.

Authors:  A Renzulli; M De Feo; A Carozza; A Della Corte; R Gregorio; G Ismeno; M Cotrufo
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

6.  Tricuspid Valve Leaflet Repair and Augmentation for Infective Endocarditis.

Authors:  Alexander A Brescia; Tessa M F Watt; Aaron M Williams; Matthew A Romano; Steven F Bolling
Journal:  Oper Tech Thorac Cardiovasc Surg       Date:  2019-10-25

7.  Complications of native and prosthetic valve infective endocarditis: update in 2006.

Authors:  Ignasi Anguera; Ana del Río; Asunción Moreno; Carlos Paré; Carlos A Mestres; José M Miró
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

8.  Tricuspid Valvular Regurgitation.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-02

9.  Tricuspid repair for infective endocarditis: clinical and echocardiographic results.

Authors:  A Carozza; A Renzulli; M De Feo; G Ismeno; A Della Corte; G Dialetto; M Cotrufo
Journal:  Tex Heart Inst J       Date:  2001

10.  Infective Endocarditis in Intravenous Drug Abusers.

Authors:  José M. Miró; Asuncion Moreno; Carlos A. Mestres
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.